C2A Security and Medcrypt Forge Partnership to Elevate Medical Device Security

Medcrypt's Guardian PKI and Cryptography Platform integrates into C2A Security's Product Security Orchestration Platform to provide end-to-end product security and compliance to medical device manufacturers

TEL AVIV, Israel and SAN DIEGO, July 1, 2025 /PRNewswire/ -- C2A Security, the only context-driven product security orchestration platform that addresses the specific needs of software-defined products and cyber-physical systems, and Medcrypt, the leading provider of proactive cybersecurity solutions for medical devices, today announced a strategic partnership to deliver comprehensive security solutions for the rapidly evolving medical and healthcare sector.

This collaboration leverages Medcrypt's expertise in medical device cybersecurity, providing scalable software with an expert regulatory advisory team. Coupled with C2A Security's context-based approach to product security and proven expertise in securing software-defined products in heavily regulated sectors, to meet the increasing demand from customers for comprehensive product security capabilities across the entire medical device lifecycle.

The healthcare industry faces unique and complex cybersecurity challenges, with connected medical devices becoming increasingly prevalent and the regulatory landscape intensifying. This collaboration integrates Medcrypt's Guardian Public Key Infrastructure (PKI) solution into C2A Security's Product Security Orchestration Platform, EVSec, enabling medical device manufacturers to benefit from strong authentication, encrypted communication, and compliance-ready cryptographic infrastructure, in context with their system's architecture. By embedding PKI capabilities directly into EVSec's workflows, MedTech's product security teams can now orchestrate additional security functions as device key and certificate lifecycle management, into their existing CI/CD pipelines, without disrupting developer velocity. The collaboration between C2A Security and Medcrypt validates that every software component and artifact is traceable, authenticated, and now tamper-proof, from development through post-market updates.

The partnership will provide medical device manufacturers with a holistic, AI-powered approach to product security, enabling them to better protect patient safety and sensitive health data, from design and development to post-market monitoring, aligning with FDA cybersecurity regulations and the evolving regulatory landscape.

"This partnership delivers on a clear market need: aligning deep cybersecurity expertise with operational agility," said Bob Lyle, Chief Revenue Officer at Medcrypt. "Medical device manufacturers are facing unprecedented security and compliance demands. By integrating Guardian into C2A's orchestration platform, we're enabling teams to automate PKI, streamline development, and build security in by design - from day one through post-market. This collaboration is a leap forward for proactive, lifecycle-aware product security."

"The medical and healthcare sector is at a pivotal moment, with innovation driving incredible advancements, but also introducing new cybersecurity risks that require a holistic, context-based approach," said Roy Fridman, CEO at C2A Security. "Our recent multi-year enterprise agreement with Elekta has demonstrated the critical need for an orchestration platform as EVSec, to manage the complexities of software-defined products. Our recent collaborations with partners like Deloitte, Orcanos, and now Medcrypt highlight the adaptability and strength of our solution. This partnership is a natural fit, as both companies share a commitment to securing critical cyber-physical systems."

The collaboration between C2A Security and Medcrypt underscores a shared vision for a more secure future in healthcare, enabling greater trust in connected medical technologies and ultimately enhancing patient outcomes by bringing battle-tested product security to this vital sector.

SOURCE C2A Security